Immunogenicity and Blocking Efficacy of Norovirus GII.4 Recombinant P Protein Vaccine

Noroviruses (NoVs) are the main cause of acute gastroenteritis in all ages worldwide. The aim of this study was to produce the recombinant P protein of norovirus and to demonstrate its blocking effect. In this study, the engineered strains were induced to express the P protein of NoVs GII.4, which w...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Zhendi, Shao, Qingyi, Xu, Zhangkai, Chen, Chenghao, Li, Mingfan, Jiang, Yi, Cheng, Dongqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305070/
https://www.ncbi.nlm.nih.gov/pubmed/37376442
http://dx.doi.org/10.3390/vaccines11061053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305070/
https://www.ncbi.nlm.nih.gov/pubmed/37376442
http://dx.doi.org/10.3390/vaccines11061053

Ejemplares similares